Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 98.44%5.13B | -20.78%10.32B | -26.50%7.4B | -24.68%4.82B | -0.02%2.58B | -67.79%13.03B | -69.87%10.06B | -74.18%6.4B | -77.42%2.58B | 0.70%40.45B |
| Operating income | 98.44%5.13B | -20.78%10.32B | -26.50%7.4B | -24.68%4.82B | -0.02%2.58B | -67.79%13.03B | -69.87%10.06B | -74.18%6.4B | -77.42%2.58B | 0.70%40.45B |
| Cost of sales | ---- | 11.00%-6.26B | ---- | 5.67%-2.91B | ---- | -15.37%-7.04B | ---- | 3.66%-3.09B | ---- | -1.43%-6.1B |
| Operating expenses | -33.08%-1.92B | 11.00%-6.26B | 12.01%-4.51B | 5.67%-2.91B | -7.88%-1.44B | -15.37%-7.04B | -14.93%-5.13B | 3.66%-3.09B | -14.18%-1.33B | -1.43%-6.1B |
| Gross profit | 180.57%3.21B | -32.26%4.06B | -41.57%2.88B | -42.38%1.91B | -8.44%1.15B | -82.56%5.99B | -82.95%4.93B | -84.64%3.32B | -87.83%1.25B | 0.57%34.35B |
| Selling expenses | -12.94%-2.08M | 37.65%-10.17M | 40.63%-7.18M | 41.50%-4.91M | 51.01%-1.84M | 51.69%-16.32M | 55.23%-12.09M | 61.46%-8.39M | 52.43%-3.76M | -16.32%-33.77M |
| Administrative expenses | 25.64%-132.01M | 3.08%-671.46M | 7.96%-405.12M | 5.59%-282.82M | -47.35%-177.52M | -8.05%-692.79M | 10.32%-440.16M | 17.20%-299.56M | -7.30%-120.47M | -56.62%-641.18M |
| Research and development expenses | -45.87%-12.88M | -9.11%-47.59M | -2.42%-29.78M | 4.13%-18.43M | -1.94%-8.83M | -43.61%-43.62M | -38.85%-29.08M | -31.40%-19.22M | -10.88%-8.67M | -13.75%-30.38M |
| Profit from asset sales | 539.79%3.39M | ---- | --27.32K | ---- | --529.65K | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | -19,874.75%-53.7M | ---- | 291.73%13.42M | ---- | -94.61%271.56K | ---- | ---7M | ---- | --5.04M | ---- |
| -Changes in the fair value of other assets | -19,874.75%-53.7M | ---- | 291.73%13.42M | ---- | -94.61%271.56K | ---- | ---7M | ---- | --5.04M | ---- |
| Impairment and provision | 558.70%90.19M | 90.61%-280.11M | 47.03%-238.59M | 42.21%-177.76M | 63.30%-19.66M | -358.82%-2.98B | -1,290.91%-450.39M | -443.32%-307.58M | -169.41%-53.58M | -950.67%-650.32M |
| -Other impairment is provision | 558.70%90.19M | 90.61%-280.11M | 47.03%-238.59M | 42.21%-177.76M | 63.30%-19.66M | -358.82%-2.98B | -1,290.91%-450.39M | -443.32%-307.58M | -169.41%-53.58M | -950.67%-650.32M |
| Special items of operating profit | 146.31%492.4M | 343.62%889.81M | 157.45%488.65M | 730.26%712.67M | 115.14%199.91M | -151.96%-365.25M | -126.01%-850.62M | -74.51%85.84M | -189.95%-1.32B | -45.38%702.92M |
| Operating profit | 217.77%3.58B | 108.45%3.94B | -14.10%2.67B | -22.67%2.14B | 532.72%1.13B | -94.39%1.89B | -90.16%3.11B | -87.20%2.77B | -102.23%-260.71M | -3.49%33.7B |
| Financing income | -37.24%29.83M | ---- | -30.84%158.29M | ---- | -54.71%47.53M | ---- | -10.71%228.89M | ---- | 48.55%104.95M | ---- |
| Financing cost | 28.20%-114.34M | -3.58%-622.01M | -1.21%-480.77M | -12.31%-324.16M | -12.28%-159.24M | -9.17%-600.53M | -17.35%-475.03M | -20.95%-288.63M | -47.98%-141.82M | 49.19%-550.1M |
| Share of profits of associates | ---- | 172.84%648.82M | ---- | 119.41%221.28M | ---- | -129.66%-890.78M | ---- | -155.87%-1.14B | ---- | -49.05%3B |
| Share of profit from joint venture company | ---- | -102.39%-517K | ---- | ---- | ---- | -80.96%21.65M | ---- | --11.47M | ---- | --113.72M |
| Special items of earning before tax | 424.33%12.62M | ---- | 64.27%-9.59M | ---- | -154.55%-3.89M | ---- | -285.92%-26.84M | ---- | 2,724.94%7.14M | ---- |
| Earning before tax | 241.68%3.75B | 844.28%3.97B | -3.94%2.89B | 50.90%2.04B | 316.28%1.1B | -98.84%419.92M | -90.52%3B | -94.24%1.35B | -104.31%-507.22M | -8.72%36.26B |
| Tax | ---- | 25.65%-966.78M | ---- | 40.60%-522.33M | ---- | 87.75%-1.3B | ---- | 87.31%-879.35M | ---- | -20.47%-10.62B |
| After-tax profit from continuing operations | 263.10%2.84B | 440.59%3B | 26.03%2.19B | 222.00%1.51B | 194.21%782.46M | -103.43%-880.38M | -92.25%1.73B | -97.15%470.24M | -109.82%-830.56M | -17.04%25.64B |
| Earning after tax | 263.10%2.84B | 440.59%3B | 26.03%2.19B | 222.00%1.51B | 194.21%782.46M | -103.43%-880.38M | -92.25%1.73B | -97.15%470.24M | -109.82%-830.56M | -17.04%25.64B |
| Minority profit | 42.31%965.09M | -67.63%2.54B | -73.03%2.01B | -74.82%1.43B | -77.88%678.18M | -57.28%7.85B | -47.90%7.44B | -43.52%5.67B | -14.32%3.07B | 163.56%18.37B |
| Profit attributable to shareholders | 1,699.12%1.88B | 105.25%458.43M | 103.16%179.9M | 101.67%86.65M | 102.68%104.27M | -219.90%-8.73B | -170.40%-5.7B | -180.64%-5.2B | -179.93%-3.9B | -69.60%7.28B |
| Basic earnings per share | 1,766.67%1.12 | 105.26%0.28 | 103.16%0.11 | 101.58%0.05 | 102.52%0.06 | -219.82%-5.32 | -170.59%-3.48 | -180.66%-3.17 | -180.13%-2.38 | -71.19%4.44 |
| Diluted earnings per share | 1,733.33%1.1 | 105.26%0.28 | 103.16%0.11 | 101.58%0.05 | 102.52%0.06 | -219.82%-5.32 | -170.59%-3.48 | -180.66%-3.17 | -180.13%-2.38 | -71.19%4.44 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.